Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Journal of Immunological Methods|September 16, 2003
Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFATNiels Schaft, Birgit Lankiewicz, Jan Willem Gratama, et al.
Journal of Immunology Research|July 23, 2016
Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional ManipulationIlka Knippertz, Andrea Deinzer, Jan Dörrie, et al.
International Journal of Molecular Sciences|September 27, 2025
STINGing Cancer: Development, Clinical Application, and Targeted Delivery of STING AgonistsYannick Gabriel Nerdinger, Amanda Katharina Binder, Franziska Bremm, et al.
International Journal of Molecular Sciences|November 13, 2021
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell StimulationStefanie Hoyer, Valentina Eberlein, Gerold Schuler, et al.
Plos One|February 9, 2013
Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitinChristian Setz, Melanie Friedrich, Sabine Hahn, et al.
International Journal of Molecular Sciences|July 12, 2025
Rendering NK Cells Antigen-Specific for the Therapy of Solid TumoursCarina A Doeppner, Amanda Katharina Binder, Franziska Bremm, et al.
Anticancer Research|May 29, 2017
Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic MelanomaUgur Uslu, Michael Erdmann, Stefan Schliep, et al.
International Journal of Molecular Sciences|January 19, 2018
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell TherapyJan Dörrie, Lek Babalija, Stefanie Hoyer, et al.
Pharmaceutics|March 27, 2025
The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible?Lisa Arnet, Lisabeth Emilius, Annett Hamann, et al.
Cancers|October 27, 2022
Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T CellsDennis Christoph Harrer, Charlotte Schenkel, Carola Berking, et al.
Pageof 9